THAR: Nilai perusahaan marang bathi resik Tharimmune Inc
Tharimmune, Inc. (THAR) develops specific antibodies to combat tumors and autoimmune pathologies, leveraging patented technologies and a debt-free balance sheet. This daily price chart on GURU.Markets shows that the multiple is -18.40. The business operates within the US legal framework, which mitigates external political risks. However, the company faces intense pressure from pharma behemoths that possess colossal resources for expansion.
%20Pangali%20P%2FE&width=1200&height=400&colorIndex=0&v=mwejrfjc.e5f-7d7lczk&start=20220704&end=20261113&filename=GURU_Markets_-_THAR_-_Tharimmune-Inc._-_PE-Multiple "THAR: Koefisien rega marang bathi tharimmune.com 21.02.2024 - 18.02.2026 | 👁️GURU.Markets👁️")
Rincian metrik komprehensif lan analitis Tharimmune Corp (THAR)
- rega saham lan prakiraan rega para ahli:
- informasi kapitalisasi pasar:
- indikator nilai aset resik miturut neraca:
- informasi babagan utang lan solvabilitas:
Rasio Kabeh Utang marang Dana Pribadi Tharimmune, Inc.|THAR - Utang jangka dawa marang modal|Kewajiban jangka cendhak marang modal Tharimmune Corporation|THAR - Gunggung utang perusahaan|Utang marang modal buku Tharimmune, Inc.|THAR - Utang jangka dawa perusahaan|Silihan lan utang jangka cendhak perusahaan Tharimmune|Rasio cepet tharimmune.com
- indikator profitabilitas perusahaan lan kelipatan valuasi:
THAR - Bathi resik perusahaan|Penghasilan resik sing dikarepake Tharimmune, Inc.|THAR - Pangali P/E|Kapitalisasi marang proyeksi bathi Tharimmune Inc|THAR - Rasio rega marang bathi tumrap wutah|Rasio nilai perusahaan marang bathi sadurunge bunga, pajeg, lan panyusutan Tharimmune, Inc.|THAR - Bathi sadurunge mbayar bunga, pajak, lan amortisasi|Bathi resik saben saham sajrone 12 wulan pungkasan Tharimmune|THAR - Bathi resik saben saham sajrone 12 wulan pungkasan|Wutah bathi EPS kuartalan tharimmune.com|THAR - Wutah bathi saben saham ing taun lumaku|Proyeksi kacepetan wutah bathi saben saham kanggo taun ngarep Tharimmune, Inc.
- rincian pendapatan lan dodolan emiten:
Analisis umum perusahaan:tharimmune.com, THAR
This ratio serves as a key filter during asset stress testing, allowing for the determination of the overpayment level per unit of net profit. The ratio of market capitalization to annual income reflects investor expectations, while the target P/E of Tharimmune, Inc. (THAR) demonstrates the extent to which the valuation of Tharimmune, Inc. (THAR) is subject to pressure from pharma behemoths dominating the cancer immunotherapy sector.
Pesaing wigati
ONC: Nilai perusahaan marang bathi resik|Koefisien rega marang bathi HALO (Halozyme)|RVMD (Revolution Medicines Inc) - Nilai perusahaan marang bathi resik|Pangali P/E AAPG (Ascentage)|CGON - Koefisien rega marang bathi|URGN: Koefisien rega marang bathi|BCAX - Pangali P/E|Personalis (PSNL) - Rasio rega marang bathi|Erasca Inc - Nilai perusahaan marang bathi resik|DCTH (Delcath) - Pangali P/E|Kapitalisasi marang bathi Y-mAbs Corp YMAB|Koefisien rega marang bathi AURA (Aura Biosciences, Inc.)|Rasio rega pasar marang bathi resik CADL|Pangali P/E ARAY (Accuray)|Nilai perusahaan marang bathi resik SLS|Actuate Therapeutics, Inc - Pangali P/E|CTOR - Pangali P/E|tuhurabio.com (HURA) - Rasio rega marang bathi|protaratx.com - Nilai perusahaan marang bathi resik|FATE (Fate Therapeutics) - Pangali P/E|Aadi Bio (WHWK) - Periode bali modal bisnis|Rasio rega marang bathi TScan Therapeutics (TCRX)|Koefisien rega marang bathi championsoncology.com CSBR|Rasio rega marang bathi XBiotech XBIT|CVM - Koefisien rega marang bathi|OSTX: Koefisien rega marang bathi|RADX - Pangali P/E|artivabio.com (ARTV) - Rasio rega marang bathi|Pangali rega marang bathi ANL|VERU (Veru Inc.) - Pangali P/E|Kapitalisasi marang bathi tempesttx.com TPST|Koefisien rega marang bathi XLO (Xilio Therapeutics, Inc.)|RENB (renovarobio.com) - Nilai perusahaan marang bathi resik|Pangali P/E MURA (Mural Oncology)|Periode bali modal bisnis Kairos Pharma Limited (KAPA)|OKUR - Rasio rega marang bathi|GDTC (CytoMed Therapeutics) - Pangali rega marang bathi|CRIS: Pangali P/E|Koefisien rega marang bathi Apollomics|Koefisien rega marang bathi ADVB|Genprex Inc (GNPX) - Periode bali modal bisnis|Koefisien rega marang bathi CLDI (Calidi Biotherapeutics)|Rasio rega pasar marang bathi resik SBFM|Pangali P/E XBIO (Xenetic Biosciences, Inc.)|Nilai perusahaan marang bathi resik SLRX|Purple Biotech Corp - Pangali P/E|AONC - Pangali P/E|BeiGene, Ltd. (BGNE) - Rasio rega marang bathi|checkpointtx.com - Nilai perusahaan marang bathi resik|ELEV (Elevation Oncology) - Pangali P/E|Koefisien rega marang bathi iCAD Corp (ICAD)|Pangali P/E IKNA|Pangali P/E Notable Labs Corp (NTBL)|Rasio rega marang bathi Viracta Therapeutics, Inc. VIRX|MOR: Pangali rega marang bathi|NAYA Biosciences Inc. - Pangali P/E|Ascentage Pharma Group International (AAPGV) - Koefisien rega marang bathi
